Duff & Phelps Investment Management Co. Acquires 778,355 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Duff & Phelps Investment Management Co. raised its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 58.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 2,101,595 shares of the real estate investment trust's stock after acquiring an additional 778,355 shares during the quarter. Duff & Phelps Investment Management Co. owned approximately 0.91% of Sabra Health Care REIT worth $29,990,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of SBRA. CWM LLC increased its holdings in Sabra Health Care REIT by 363.5% in the third quarter. CWM LLC now owns 1,780 shares of the real estate investment trust's stock valued at $25,000 after purchasing an additional 1,396 shares during the period. Tennessee Valley Asset Management Partners bought a new stake in shares of Sabra Health Care REIT in the 4th quarter valued at about $25,000. GAMMA Investing LLC acquired a new stake in shares of Sabra Health Care REIT in the fourth quarter valued at about $33,000. Signaturefd LLC boosted its stake in shares of Sabra Health Care REIT by 45.2% in the 3rd quarter. Signaturefd LLC now owns 2,610 shares of the real estate investment trust's stock valued at $36,000 after purchasing an additional 813 shares during the last quarter. Finally, Headlands Technologies LLC acquired a new stake in shares of Sabra Health Care REIT during the third quarter worth $48,000. Institutional investors own 99.40% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on SBRA shares. Wedbush reaffirmed an "outperform" rating and set a $17.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Deutsche Bank Aktiengesellschaft started coverage on Sabra Health Care REIT in a research note on Tuesday, January 30th. They set a "buy" rating and a $21.00 target price for the company. Finally, Mizuho lifted their target price on Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a "buy" rating in a report on Wednesday, January 3rd. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $15.77.

Sabra Health Care REIT Stock Down 1.8 %

SBRA stock traded down $0.25 during midday trading on Tuesday, reaching $13.92. 1,566,342 shares of the company's stock traded hands, compared to its average volume of 2,020,617. The company has a quick ratio of 3.41, a current ratio of 3.41 and a debt-to-equity ratio of 0.86. The firm's fifty day moving average price is $14.07 and its 200-day moving average price is $14.04. Sabra Health Care REIT, Inc. has a 52 week low of $10.30 and a 52 week high of $14.91. The company has a market cap of $3.22 billion, a price-to-earnings ratio of 278.40, a P/E/G ratio of 5.01 and a beta of 1.16.

Sabra Health Care REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, February 29th. Stockholders of record on Tuesday, February 13th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 8.62%. The ex-dividend date was Monday, February 12th. Sabra Health Care REIT's payout ratio is presently 2,400.00%.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.